McKesson, CD&R sign $5.8 billion agreement to buy Option Care Health

CD&R and McKesson have signed an agreement to acquire infusion-therapy provider Option Care Health for $32.05 per share, about $5.8 billion, announced October 6, 2026, according to CD&R. The per-share price is what counts for shareholders; the $5.8 billion is an approximate headline figure.